该职位已失效,看看其他机会吧

QA

2万-3万·13薪
  • 南京江宁区
  • 5-10年
  • 本科
  • 全职
  • 招1人

职位描述

药品临床研究

岗位职责:
1、Develops, maintains, and oversees the GxP quality system and associated strategy, processes, tools, and technologies for Mitro China, US and UK .
2、Develop and lead the audit process, including site audit, vendor audit etc..
3、Leads GxP audit response management and audit/inspection CAPAs to ensure suitability. Ability to lead GCP inspection readiness activities and support global health authority inspections.
4、Represent QA in issue escalation meetings. Risk assessment and remediation activities, major GCP issue investigation, trend analysis, CAPA and validity check in conjunction with local / global stakeholders/Customers.
5、Collaborates with clinical team to identify training needs for China, US, UK. Plans and provides training to clinical team. Review and update training curriculum in the Learning Management System.
6、Support the clinical team to develop clinical related procedure docs.

任职要求:
1、At least 5 years with MNC pharmaceutical R&D or global CRO quality related experiences.
2、Strong knowledge of GCP and ICH E6 R2.
3、Broad knowledge of global and Chinese regulatory requirements related to clinical studies.
4、GxP audit and inspection readiness experiences are required.
5、QMS establishment and implementation experiences are preferrable.
6、Bachelors or equivalent degree, health related (e.g., Medical, Scientific, Nursing, Pharmacy) preferred
7、Proficient in verbal and written English.


查看全部

工作地点

南京生命科技小镇加速带乾德路5号8号楼

职位发布者

邹燕/人事主管

立即沟通
公司Logo米度(南京)生物技术有限公司
米度(南京)生物技术有限公司,简称米度生物(MITRO Biotec),专注于分子影像转化医学研究,主要从事分子影像药物研发外包、药物标记合成、新型核医学示踪剂及分子探针研究、肿瘤靶向治疗技术研究。米度生物利用先进核医学设备和活体分子影像技术,为新药研发提供从动物到人体的全流程技术服务。临床前研究方面,通过活体分子影像技术,动态、定量、精准获取小动物体内药代动力学(PK)和药效学(PD)数据,对国内外制药企业、高校院所、临床医疗机构等提供从药物筛选、分布代谢、疗效及安全性评价等的一系列的药物研发整体解决方案和全套技术服务,帮助客户降低药研成本、缩短研发周期、加快新药上市。临床研究方面,利用人体PET、SPECT等先进分子影像技术手段,开展临床0期(人体微剂量,HumanMicrodosing)研究及指导个体化医疗(Personalized Medicine)实践,加快药物研发,降低失败风险,服务百姓健康,为科研成果直接转化开辟出新途径。分子影像技术具有活体显像、自身对照、连续观察、动态定量等特点,缩短研发周期、加快新药上市。
公司主页